Brief: Kyowa Kirin Announces Changes In Top Leadership Positions To Strengthen Operations As A Global Specialty Pharmaceutical Company
31/10/2024 11:34
Oct 31 (Reuters) - Kyowa Kirin Co Ltd 4151.T :
* KYOWA KIRIN ANNOUNCES CHANGES IN TOP LEADERSHIP POSITIONS
TO
STRENGTHEN OPERATIONS AS A GLOBAL SPECIALTY PHARMACEUTICAL
COMPANY
* KYOWA KIRIN CO LTD - MASASHI MIYAMOTO TO BE NAMED CHAIRMAN
AND
CEO
Source text: ID:nPn934M5Ba
Further company coverage: 4151.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kyowa Kirin
See all newsFactbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Factbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Brief: Kyowa Kirin Announces Agreement With US Administration To Reduce Treatment Costs For Americans
Table: Kyowa Kirin 6-MTH group results (IFRS)
Brief: Kyowa Kirin Says European Commission Approves Crysvita For Infants With X-Linked Hypophosphataemia